Quantcast

Latest drug discovery Stories

2014-05-15 12:33:45

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Marketshttp://www.reportbuyer.com/pharma_healthcare/diseases/sample_preparation_genomics_proteomics_epigenomics.html STUDY GOALS AND OBJECTIVESThis BCC Research report, Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets, provides an overview of the current overall state of the sample preparation...

2014-05-15 12:29:33

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Markets for Orphan Drugshttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/global_markets_orphan_drugs.htmlINTRODUCTIONSTUDY OBJECTIVESThe orphan drug market is one of the fastest-growing segments in the pharmaceutical and biotechnology industry. BCC's goal in conducting this study is to provide an overview of the current and future global market for orphan drugs. The key...

2014-05-15 04:22:26

LONDON and BOSTON, May 15, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that Fiona Marshall, Heptares' Chief Scientific Officer and co-founder, will give a company presentation at the UBS Global Healthcare Conference [https://www.ubs.com/global/en/investment-bank/key-investor-conferences/americas.html ] in New York City, NY, USA. The presentation will take place at 9:00am EDT on Monday 19 May....

2014-05-14 23:09:18

New Kauffman Foundation paper highlights solutions to speed patients’ access to drugs with therapeutic value for more than one disease. Kansas City, MO (PRWEB) May 14, 2014 For patients with rare medical conditions, the typical 12 to 15 years it takes to bring a new drug to market may be too long to wait. Repurposed drugs – those already approved for a specific condition that can be used to treat another – offer a solution: Because their safety profile is already established, they...

2014-05-14 23:02:07

The new NextGEN™ CRISPR genome engineering tools and services provided by Transposagen are ideal when research and drug discovery applications require clean, high-precision genome editing. Lexington, KY (PRWEB) May 14, 2014 Altering the genome with targeted nucleases is powerful and increasingly necessary for research and drug discovery. The CRISPR-Cas9 system has gained popularity due to its simplicity and high efficiency. While the original CRISPR technology is not owned or...

2014-05-14 12:31:15

LONDON, May 14, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Biopreservation Market (Product Types - Equipment, LIMS, and Media; Applications - Regenerative Medicine, Biobanking, and Drug Discovery) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 -...

2014-05-14 08:29:39

BALLERUP, Denmark, May 14, 2014 /PRNewswire/ -- Sophion Bioscience (sophion.com [http://sophion.com ]), part of Biolin Scientific, has received its first purchase orders for its new high throughput screening platform from leading pharma companies. The Sophion Qube(TM) measures the effect of potential new drug candidates directly on ion channels in living cells. By a unique combination of high quality recordings and high throughput, the Sophion Qube can boost the productivity...

2014-05-13 23:08:34

Major Pharmaceutical Companies Serving in ADDPLAN DF Consortium Providing Early Feedback Dublin, Ireland (PRWEB) May 13, 2014 ICON plc (NASDAQ: ICLR), today announced that Aptiv Solutions, an ICON plc company leading the design and implementation of adaptive trials, has released ADDPLAN® DF 3.0, which incorporates complex statistical methodologies to prevent under and over-estimation of a therapeutic’s maximum target dose (MTD) during Phase I dose escalation trials. Accurate...

2014-05-13 23:02:01

Sessions to provide key regulatory updates from international leaders Washington (PRWEB) May 13, 2014 Leading drug and medical device regulators from around the world will offer insight on their home countries’ and continents’ regulatory landscape during town hall sessions at the DIA 2014 50th Annual Meeting, from June 15 to 19 at the San Diego Convention Center. Regulatory innovators from the U.S., Europe, Canada and Asia will lead the discussions. Guido Rasi, executive director of...

2014-05-13 23:01:47

Patient to drive enrollment discussion by sharing experience in clinical trials. Washington (PRWEB) May 13, 2014 Experts dedicated to enhancing clinical trials will explore hurdles in patient enrollment at the DIA 2014 50th Annual Meeting, from June 15 to 19 in San Diego. The session, “The Patient Point-of-View: An Unrehearsed but Revealing Conversation to Rectify Patient Enrollment,” will feature the perspective of T.J. Sharpe, a prominent patient advocate who was the first to...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related